TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text

Medicine, Oncology, Radiation Oncology +12

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.8K citations

Medicine, Oncology, Radiation Oncology +17

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Nature · 2008 · 7.8K citations · Full text

Medicine, Molecular Genetics, Oncology +12

The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma

Krishna Bhat, Katrina L. Salazar, Veerakumar Balasubramaniyan et al. · Genes & Development · 2011 · 375 citations · Full text

Medicine, Genetics, Oncology +17

TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells

Monica Bartucci, Rosanna Dattilo, Chiara Moriconi et al. · Oncogene · 2014 · 361 citations

Medicine, Cell Biology, Oncology +14